Clinical Trial Challenges
Charles discusses the high costs and long timelines of clinical trials, revealing a staggering 90% failure rate for drugs entering these trials. The conversation delves into the need for innovative solutions to streamline the process and align it better with patient needs.In this clip
From this podcast
This Week in Startups
Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734
Related Questions